Guillem Singla Buxarrais
Guillem Singla Buxarrais is co-founder and CEO of Neurofenix, the company building revolutionary devices to improve rehabilitation. Guillem has worked on cutting-edge research at the Brain and Behaviour Lab at the UK's leading Department of Bioengineering, Imperial College.
He built the NeuroBall working alongside physiotherapists from Brunel University London. He used his extensive experience and hundreds of hours volunteering with stroke survivors to create the NeuroBall. The NeuroBall is a revolutionary games controller that makes upper limb rehabilitation more engaging and accessible.
Guillem is an innovative Biomedical Engineer who has received recognition from the Institute of Engineering and Technology and The Royal Academy of Engineering. He was also awarded the prestigious Inventor Prize by Nesta and the Department for Business, Energy and Industrial Strategy (BEIS). The award recognised the profound impact the Neuroball will have on the lives of millions of stroke survivors worldwide.
How to utilise the Neuroscience of habits for rehabilitation
When you got ready this morning, did you put on your left or right shoe first? Don’t know the answer? You are not alone. Habits shape our everyday lives. In this seminar, you’ll learn about the neuroscience behind habit formation. We explore how we can utilise this to build habits for success in rehabilitation… and everything else.
EVEN MORE SEMINARS
Maroun Farah Senso Medical Labs
BioPot platform: development of EEG, EMG and Bioimpedance patch and tattoo wearables
Ms Kayleigh Wain Priory Healthcare
Communication and Swallowing Disorders common in Acquired Brain Injury
Dr Camilla Nord University of Cambridge
Neurobiological predictors of response to tDCS-enhanced psychological therapy in depression
Khashayar Pazooki Groupe Psylux S.A. / Neuroacademy Luxembourg
QEEG /ERP & psychometry into an individualized & personalized medicinal treatment Model of psychiatric disorders
Susan Wood Matthew’s Friends Clinics
Ketogenic Diet Therapy in Adults; complex epilepsy and beyond.